Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

Ilaria Marigo, Luigi Dolcetti, Paolo Serafini, Paola Zanovello, Vincenzo Bronte

Research output: Contribution to journalArticlepeer-review

Abstract

Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.

Original languageEnglish
Pages (from-to)162-179
Number of pages18
JournalImmunological Reviews
Volume222
Issue number1
DOIs
Publication statusPublished - Apr 2008

Keywords

  • Arginine metabolism
  • Cancer
  • Immunosuppression
  • MDSC
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells'. Together they form a unique fingerprint.

Cite this